ADIPOQ and fatty liver disease: Patients with hepatic steatosis diagnosed by TE had significantly higher serum levels of leptin (P < 0.001), insulin (P = 0.002), HOMA2-IR (P < 0.001) and lower levels of serum adiponectin (P = 0.015) compared to the patients without hepatic steatosis in TE.